ISLAMORADA, Fla., April 26, 2021 /3BL Media/ - Despite a decade of community opposition, the experimental release of genetically engineered mosquitoes begins today in the Florida Keys. British biotech corporation, Oxitec, in collaboration with the Florida Keys Mosquito Control District, plans to release up to a billion genetically engineered mosquitoes in two phases. GMO Free USA and the Coalition Against GMO Mosquitoes condemn the uncontrolled release and are airing radio spots to educate Florida Keys residents about the health and environmental risks.
CRB-designed facility supports work to remap mosquito genes in fight against infectious disease
The highly complex and scientific battle to contain, treat and one day cure mosquito-borne disease is being waged on groundbreaking fronts. One of them is at a laboratory at the University of California, San Diego, where scientists are working obsessively to re-map arthropod genetics and, ultimately, flip the script on infectious illnesses.
- Building on the company's successful history in developing vaccines against similar viruses, most recently the introduction of Dengvaxia® against dengue, Sanofi Pasteur is launching a Zika vaccine project -
LYON, France, March 10, 2016 /3BL Media/ - Sanofi Pasteur, the vaccines division of Sanofi, announced today that it has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.
The parasite that causes malaria has shown it is adept at eluding the human immune system. Will that parasite also outrun the prevention and control efforts of global health organizations, governments, healthcare systems, pharmaceutical companies and communities? We are at a critical time to answer that question.